arBtrage CAPITALIZING MARKETS checking… Sign in

Karyopharm Therapeutics Inc.

KPTI Health Care Biotechnology: Pharmaceutical Preparations
$9.08
▲ +0.1% Today
as of Jun 7, 07:19 ET
Last 30 days +5.58% Apr 28 → Jun 05
$6.93 $7.70 $8.48 $9.26 $10.03 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$9.04
High
$9.23
Low
$8.85
Volume
$262,346
Avg Vol
$432,454
Mkt Cap
$206M
P/E (TTM)
Beta
52w High
$10.99
52w Low
$3.65
Div Yield
Shares Out
$23M

Overview

52-week range
$3.65
$11
74% of range
Avg surprise (last 2)
+24.3%
Avg reaction (last 2)
+1.4%
100% positive
Latest IV / EM
87%
EM ±12.1% · $10 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-4.85$-3.71$-2.57$-1.43$-0.29 Actual $-0.29Actual $-0.30Actual $-4.85Actual $-2.97Actual $-3.85Actual $-2.77Est $-4.21Actual $-4.32Actual $-3.82Actual $-1.24Est $-1.45 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-37M$-16M$4M$25M$46M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-1.24 $-1.45 +14.5% +55.2% +0.6% earnings
Tue Sep 30, 2025Sep 2025 $-3.82 financials
Mon Jun 30, 2025Jun 2025 $-4.32 financials
Mon May 12, 2025Mar/2025 $-2.77 $-4.21 +34.2% +2.3% earnings
Mon Sep 30, 2024Sep 2024 $-3.85 financials
Sun Jun 30, 2024Jun 2024 $-2.97 financials
Sun Mar 31, 2024Mar 2024 $-4.85 financials
Sat Sep 30, 2023Sep 2023 $-0.30 financials
Fri Jun 30, 2023Jun 2023 $-0.29 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$35M$44M$38M$30M$39M$43M
Cost of revenue
Gross profit
Operating income$-27M$-15M$-24M$-33M$-26M$-28M
Net income$-22M$-33M$-37M$-23M$-32M$24M
EPS (diluted)$-1.24$-3.82$-4.32$-2.77$-3.85$-2.97

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$91M$61M$38M$39M$39M$62M$73M$85M
Inventory$4M$4M$4M$5M$5M$5M$5M$3M
Total current assets$126M$103M$90M$98M$120M$156M$185M$209M
Total assets$131M$108M$96M$105M$128M$164M$189M$214M
Long-term debt
Total liabilities$397M$401M$365M$344M$334M$350M$349M$346M
Total equity$-266M$-293M$-269M$-239M$-206M$-186M$-160M$-132M

Implied volatility — last 90 days

82%84%87%89%92% Jun 07 — IV 87% · EM ±12.1%

Sector peers